|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,428.50 INR | +0.24% |
|
+1.51% | -1.42% |
| 02/06 | Alkem Laboratories Limited Launches Semaglutide in Single-Shot Pre-Filled Syringes At Price Starting Inr 350 | CI |
| 02/06 | Alkem Laboratories Shows Strong Moves But Weak Follow-Through |  |
| Market Cap | 65TCr 688.59Cr 606.24Cr 559.18Cr 522.99Cr 979.9Cr 998.19Cr 6.72TCr 2.6TCr 32TCr 2.59TCr 2.53TCr 1,11400Cr | P/E 2026 |
27.5x | P/E 2027 * | 27.7x |
|---|---|---|---|---|---|
| Enterprise Value | 62TCr 658.75Cr 579.96Cr 534.94Cr 500.32Cr 937.42Cr 954.92Cr 6.43TCr 2.49TCr 31TCr 2.47TCr 2.42TCr 1,06600Cr | EV / Sales 2026 |
4.3x | EV / Sales 2027 * | 3.74x |
| Free-Float |
37.09% | Yield 2026 |
1% | Yield 2027 * | 0.95% |
Last Transcript: Alkem Laboratories Limited
| 1 day | +0.24% | ||
| 1 week | +1.51% | ||
| Current month | -1.26% | ||
| 1 month | +0.44% | ||
| 3 months | +5.52% | ||
| 6 months | -3.01% | ||
| Current year | -1.42% |
| 1 week | 5,321 |  | 5,511 |
| 1 month | 5,162.5 | | 5,789 |
| Current year | 5,075 | | 5,933.5 |
| 1 year | 4,716.2 | | 5,933.5 |
| 3 years | 3,335.8 | | 6,439.9 |
| 5 years | 2,828 | | 6,439.9 |
| 10 years | 1,341 | | 6,439.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Vikas Gupta
CEO | Chief Executive Officer | - | 22/09/2023 |
Rajorshi Ganguli
PSD | President | - | - |
Akhilesh Sharma
PSD | President | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sandeep Singh
BRD | Director/Board Member | 43 | 09/08/2013 |
| Director/Board Member | 63 | 11/02/2008 | |
Sarvesh Singh
BRD | Director/Board Member | 44 | 11/11/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.24% | +1.51% | +14.04% | +62.05% | 683.53Cr | |
| +0.92% | +0.47% | +43.59% | +146.77% | 99TCr | |
| +0.80% | +2.90% | +58.35% | +47.28% | 58TCr | |
| +0.06% | +6.17% | +26.59% | +74.06% | 41TCr | |
| +3.61% | -1.30% | +22.76% | +15.66% | 32TCr | |
| +2.35% | +4.71% | +33.49% | +21.78% | 28TCr | |
| +0.75% | +3.88% | +30.77% | +37.10% | 28TCr | |
| +1.23% | +11.15% | -30.87% | -42.75% | 21TCr | |
| +1.27% | +2.86% | +26.65% | +56.38% | 19TCr | |
| +0.09% | -0.23% | +16.75% | +63.48% | 16TCr | |
| Average | +0.97% | +1.49% | +24.21% | +48.18% | 34.12TCr | |
| Weighted average by Cap. | +0.86% | +0.73% | +33.45% | +69.23% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 15TCr 155.15Cr 136.59Cr 125.99Cr 117.83Cr 220.78Cr 224.9Cr 1.51TCr 586.45Cr 7.21TCr 582.5Cr 569.87Cr 25TCr | 17TCr 175.63Cr 154.63Cr 142.63Cr 133.39Cr 249.94Cr 254.6Cr 1.71TCr 663.9Cr 8.17TCr 659.42Cr 645.12Cr 28TCr |
| Net income | 2.51TCr 27Cr 23Cr 22Cr 20Cr 38Cr 39Cr 260.16Cr 100.77Cr 1.24TCr 100.09Cr 98Cr 4.31TCr | 2.39TCr 25Cr 22Cr 21Cr 19Cr 36Cr 37Cr 247.69Cr 96Cr 1.18TCr 95Cr 93Cr 4.11TCr |
| Net Debt | -2.81TCr -30Cr -26Cr -24Cr -23Cr -42Cr -43Cr -291.27Cr -112.82Cr -1.39TCr -112.06Cr -109.63Cr -4.83TCr | -3.05TCr -32Cr -28Cr -26Cr -25Cr -46Cr -47Cr -315.52Cr -122.21Cr -1.5TCr -121.39Cr -118.76Cr -5.23TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/26/24 | ₹5,428.50 | +0.24% | 1,24,021 |
| 23/26/23 | ₹5,415.50 | +0.90% | 2,10,575 |
| 22/26/22 | ₹5,367.00 | -0.12% | 1,06,481 |
| 19/26/19 | ₹5,373.50 | +0.03% | 82,881 |
| 18/26/18 | ₹5,372.00 | +0.46% | 75,504 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ALKEM Stock
Select your edition
All financial news and data tailored to specific country editions
